| Table of contents Vaccimonitor vol.29 no.3 Ciudad de la Habana Sept.-Dec. 2020 ARTICULOS ORIGINALES | | | | · Biological risk assessment for the production of inactivated vaccines for animal use Solórzano-Álvarez, Ernestina; Pérez-Tortoló, Joselyn; Rodríguez-Dueñas, José
| | | | · Immunotherapy with mite allergens in patients with allergic rhinitis and obstructive sleep apnea Rodríguez-Santos, Olimpio; García-Asensi, Alfonso; Valle-Monteagudo, Nancy del; Galeana-Ríos, Roberto; Flores-Silverio, Zuriel
| | | | · Application of Principal Component Analysis on dimers formation during a monoclonal antibody's purification Regalado-Fonseca, Ivis; Mora-Montes de Oca, Osvaldo; Zumalacárregui-de Cárdenas, Lourdes
| | | | · Risk-management related to the productive campaign change during technological development stage in a multi-product facility Apezteguía-Rodríguez, Isabel; Díaz-Montel, Belinda; García-Martínez, Yanara; Trimiño-Lorenzo, Lian; Soler-Sánchez, Dayana; Font-Echevarría, Bárbara; Muñoz-Hernández, Lázara; Hernández-Pérez, Lourdes; García-Martínez, Ilena; Torres-Idavoy, Ramira Dinorah
| | | | · Characterization of allergic patients to bee sting that receive immunotherapy Bocourt-Esmeiro, Fabiola María; López-González, Belkis; Álvarez-Castelló, Mirta; Castro-Almarales, Raúl L.; Rodríguez-Canosa, José S.; Torres-Concepción, Jorge
| | | | · Expression in Saccharomyces boulardii of recombinant Toxin-coregulated pilus A subunit (TcpA) of Vibrio cholerae O1 Awad, Suadad; Al-Ahmer, Saife D; Salih, Shahla'a M
| | | | · Protective efficacy of an inactivated vaccine against Rabbit hemorrhagic disease virus 2 prepared from a local isolate in Egypt Abido, Ola Y.; Abotaleb, Mahmoud M.; Yehia, Nahed; El-Deeb, Ayman H.; Amer, Aziza M.; El-Sanousi, Ahmed A.
| | |
|